Evidence map›Paper›PMID 39589623›Full record

ArticleVeterinary research communications2024

Optimum processing conditions for a trivalent-inactivated bovine viral diarrhea virus (BVDV) vaccine using field strains and immunogenicity of candidate formulations with different adjuvants.

Berfin Kadiroğlu, Kadir Yeşilbağ

Abstract read
PubMed Publisher
In one paragraph

Article in Veterinary research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Veterinary sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Berfin KadiroğluDepartment of Virology, Dicle University, Faculty of Veterinary Medicine, 21200, Diyarbakır, Türkiye.ORCID http://orcid.org/0000-0001-5969-6127
Kadir YeşilbağDepartment of Virology, Bursa Uludag University, Faculty of Veterinary Medicine, 16059, Bursa, Türkiye. kyesilbag@uludag.edu.tr.ORCID http://orcid.org/0000-0003-1793-6879

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bovine viral diarrhea virus (BVDV) is among the common bovine pathogens worldwide. One of the prominent protection measures of BVDV is vaccination. This study aimed to determine the growth characteristics, inactivation kinetics of vaccine candidates using local BVDV strains [TR-26 (BVDV-1f), TR-21 (BVDV-1l), and TR-15 (BVDV-2b)], and the serological response in experimental animals to inactivated BVDV vaccine formulations prepared with different adjuvants. Optimum MOI values for BVDV strains TR-26, TR-21, and TR-15 were determined as 0.1, 1.0, and 0.01, respectively. In addition, growth curves of TR-26, TR-21, and TR-15 strains were created, and it was determined that they reached the highest titers at 12, 48, and 36 h p.i., respectively. The strains TR-26, TR-21, and TR-15 with titers of 10

Indexed as

Bovine Virus Diarrhea-Mucosal DiseaseDiarrhea Viruses, Bovine ViralVaccines, InactivatedViral VaccinesAdjuvants, ImmunologicAdjuvants, VaccineAnimalsAntibodies, ViralCattleDiarrhea Virus 1, Bovine ViralGuinea PigsImmunogenicity, VaccineAdjuvants, ImmunologicAdjuvants, VaccineAntibodies, ViralVaccines, InactivatedViral VaccinesBVDVGrowth curveGuinea pigImmunizationInactivated vaccineInactivation kinetics

Identifiers

PMID39589623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.